Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
INTEGRATED BIOPHARMA INC shareholders approved Ratification of appointment of Marcum LLP as independent auditors for the fiscal year ending June 30, 2023 at the 2022-11-28 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2022-11-28
Exact text from the filing
Proposal No. 2 – To ratify the appointment of the Company ’ s independent auditors for the fiscal year ending June 30, 2023 The Company’s stockholders voted in favor of ratifying the appointment of Marcum LLP as the Company’s independent auditors for the fiscal year ending June 30, 2023. The final voting results were as follows: For Against Abstain 23,403,076 25,801 30,000
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
INTEGRATED BIOPHARMA INC shareholders approved Election of one Class III director for a three-year term to serve until the 2025 Annual Meeting of Stockholders at the 2022-11-28 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2022-11-28
Exact text from the filing
Proposal No. 1 – To elect one Class III director for a three-year term to serve until the 2025 Annual Meeting of Stockholders The Company’s stockholders voted for the election of one Class III director, Eric Friedman, to serve until the 2025 Annual Meeting of Stockholders (subject to his respective earlier removal, death or resignation) and until his successor is elected and qualified. The final voting results were as follows: Broker For Withheld Non-Votes Eric Friedman 21,738,259 85,901 1,634,717
View on SEC.gov